Concepedia

Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade

Casey Moore, Ching-Cheng Hsu, Wei‐Min Chen, Benjamin P.C. Chen, Chuanhui Han, Michael D. Story, Todd A. Aguilera, Laurentiu M. Pop, Raquibul Hannan, Yang-Xin Fu,

International Journal of Radiation Oncology*Biology*Physics · 2021 · 144 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

, , +17

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors

Liufu Deng, Hua Liang, Meng Xu et al. · Immunity · 2014 · 2.1K citations · Full text

, , +17

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity

Claire Vanpouille‐Box, Amandine Alard, Molykutty J. Aryankalayil et al. · Nature Communications · 2017 · 1.7K citations · Full text

, , +17

Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody

Md. Zahidunnabi Dewan, Ashley E. Galloway, Noriko Kawashima et al. · Clinical Cancer Research · 2009 · 1.6K citations · Full text

, , +17

Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer

Willemijn S.M.E. Theelen, Heike Peulen, Ferry Lalezari et al. · JAMA Oncology · 2019 · 984 citations · Full text

, , +17